Kahn Brothers (Trades, Portfolio), a distinguished investment firm founded in 1978 by Irving Kahn and his associates, recently disclosed their 13F filing for the second quarter of 2024. The firm is known for its value investing approach, closely following the principles laid out by Benjamin Graham. Kahn Brothers (Trades, Portfolio) Advisors LLC, the investment advisory arm, focuses on undervalued equity securities, employing a meticulous bottom-up stock selection strategy. This quarter's filing reveals significant adjustments in their portfolio, including new acquisitions, increased stakes, and notable reductions.
Kahn Brothers (Trades, Portfolio) introduced a new position in the following stock during the second quarter:
The firm increased its holdings in several stocks, with significant additions to:
Kahn Brothers (Trades, Portfolio) exited their positions in the following stocks:
The firm reduced its stake in several stocks, notably:
As of the second quarter of 2024, Kahn Brothers (Trades, Portfolio)' portfolio included 52 stocks. The top holdings were 12.74% in $Citigroup Inc(C-N)$ (NYSE:C), 12.32% in Merck & Co Inc (NYSE:MRK), 9.95% in BP PLC (NYSE:BP), 8.03% in GSK PLC (NYSE:GSK), and 6.61% in New York Community Bancorp Inc (NYSE:NYCB). The holdings are mainly concentrated across 10 of the 11 industries, including Healthcare, Financial Services, Energy, Communication Services, Industrials, Technology, Utilities, Real Estate, Consumer Defensive, and Consumer Cyclical.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。